Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 2/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.36 |
| ▸ | SLC5A1 | P13866 | 13/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6985626 | 0.82 | SLC5A1 (0.43) | SLC5A1 | |
| SCHEMBL6985081 | 0.81 | SLC5A1 (0.42) | ADORA3SLC5A1ALDH1A1 | |
| SCHEMBL6983748 | 0.81 | GRM5 (0.46) | ADORA3SLC5A1ALDH1A1GAA | |
| SCHEMBL6986371 | 0.79 | ALDH1A1 (0.41) | ALDH1A1GAA | |
| SCHEMBL6987355 | 0.79 | ALDH1A1 (0.38) | ALDH1A1GAA | |
| SCHEMBL6986812 | 0.77 | ALDH1A1 (0.40) | PTGS2ALDH1A1GAA | |
| SCHEMBL6979355 | 0.77 | SOAT2 (0.42) | SLC5A1 | |
| SCHEMBL6985846 | 0.76 | BCL2 (0.41) | SLC5A1ALDH1A1GAA | |
| SCHEMBL6981802 | 0.76 | ALDH1A1 (0.42) | ALDH1A1GAA | |
| SCHEMBL6982469 | 0.75 | CYP2C9 (0.39) | ALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1313733-A1 | PYRAZOLOPYRIDINE COMPOUND AND PHARMACEUTICAL USE THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-05-28 | — | — | EP | disclosed |
| WO-2002018382-A1 | PYRAZOLOPYRIDINE COMPOUND AND PHARMACEUTICAL USE THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-03-07 | — | — | WO | disclosed |